Hikma Pharmaceuticals (OTCMKTS:HKMPF) vs. Recruit (OTCMKTS:RCRUY) Financial Survey

Hikma Pharmaceuticals (OTCMKTS:HKMPF) and Recruit (OTCMKTS:RCRUY) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations and profitability.

Profitability

This table compares Hikma Pharmaceuticals and Recruit’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Hikma Pharmaceuticals	N/A	N/A	N/A
Recruit	10.58%	19.65%	12.73%

Earnings & Valuation

This table compares Hikma Pharmaceuticals and Recruit”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hikma Pharmaceuticals	$2.88 billion	2.12	$190.00 million	N/A	N/A
Recruit	$23.67 billion	4.11	$2.44 billion	$0.33	36.82

Recruit has higher revenue and earnings than Hikma Pharmaceuticals.

Risk and Volatility

Hikma Pharmaceuticals has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. Comparatively, Recruit has a beta of 1.63, meaning that its stock price is 63% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Hikma Pharmaceuticals and Recruit, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hikma Pharmaceuticals	0	0	0	1	4.00
Recruit	0	0	0	0	0.00

Summary

Recruit beats Hikma Pharmaceuticals on 7 of the 9 factors compared between the two stocks.

About Hikma Pharmaceuticals

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.

About Recruit

Recruit Holdings Co., Ltd. provides HR technology and business solutions that transforms the world of work. It operates through three segments: HR Technology, Matching & Solutions, and Staffing. The HR Technology segment provides various technological solutions that help job seekers and employers in navigating hiring and recruitment. The Matching & Solutions segment offers HR solutions that support business clients’ recruiting and hiring activities and individual users’ job search activities through its job advertising services and placement services. This segment also provides marketing solutions that provide matching platforms for businesses in various industries, including housing and real estate, beauty, bridal, travel, dining, and others, as well as SaaS solutions, which are business and management support tools for small and medium-sized companies. The Staffing segment provides temporary staffing services in Japan, Europe, the United States, and Australia. Recruit Holdings Co., Ltd. operates in more than 60 countries. The company was formerly known as Recruit Co., Ltd. and changed its name to Recruit Holdings Co., Ltd. in October 2012. Recruit Holdings Co., Ltd. was founded in 1960 and is headquartered in Tokyo, Japan.